Mika Hosokawa

Induction of Epithelial-Mesenchymal Transition and Down-Regulation of miR-200c and miR-141 in Oxaliplatin-Resistant Colorectal Cancer Cells

Shota Tanaka, Mika Hosokawa, Takeshi Yonezawa et al. · Biological and Pharmaceutical Bulletin · 2014 · 68 citations · Full text

Pathology, Cancer Biology, Tumor Biology +20

Effects of Decitabine on Invasion and Exosomal Expression of miR-200c and miR-141 in Oxaliplatin-Resistant Colorectal Cancer Cells

Shota Tanaka, Mika Hosokawa, Kumiko Ueda et al. · Biological and Pharmaceutical Bulletin · 2015 · 45 citations · Full text

Tumor Biology, Medicine, Exosomal Expression +13

Acquired resistance to decitabine and cross-resistance to gemcitabine during the long-term treatment of human HCT116 colorectal cancer cells with decitabine

Mika Hosokawa, Saito Mai, Aiko Nakano et al. · Oncology Letters · 2015 · 35 citations · Full text

Cellular Uptake of Decitabine by Equilibrative Nucleoside Transporters in HCT116 Cells

Kumiko Ueda, Mika Hosokawa, Seigo Iwakawa · Biological and Pharmaceutical Bulletin · 2015 · 23 citations · Full text

Cellular Pharmacology, Epigenetics, Cellular Physiology +21

Improvement of resistance to oxaliplatin by vorinostat in human colorectal cancer cells through inhibition of Nrf2 nuclear translocation

Shota Tanaka, Mika Hosokawa, A Tatsumi et al. · Biochemical and Biophysical Research Communications · 2022 · 18 citations

Tumor Biology, Oncology, Medicine +7